Related Experiment Videos
Biopsy proven polymyositis in Victoria 1982-1987: analysis of prognostic factors
Abstract:
Prognostic factors were analysed in 77 patients with idiopathic inflammatory myopathy identified over a 5 year period. Formal statistical tests did not differentiate useful prognostic indices and a polymyositis disability score was devised in an attempt to gain some prognostic information. Partial (47%) or full (31%) recovery were seen in most cases with no recovery of strength (9%) and death (11%) being less common outcomes. Onset before the age of 50 and duration of symptoms of less than 12 months prior to presentation were favourable prognostic features, and treatment with regimes other than steroid therapy alone a probable favourable indicator. Level of creatine kinase (CK) at presentation and histopathological separation of dermatomyositis or polymyositis failed to alter prognosis. Most patients who died did so within the initial 6 months of treatment. Four of five patients < 50 years old with either a fatal outcome or no improvement were treated with steroids alone. Large multi-centre studies are required to provide reliable data about prognostic factors in idiopathic inflammatory myopathies and the methodology used in this study can only be regarded as providing pointers towards possible prognostic factors rather than being definitive.
Insights
Idiopathic inflammatory myopathy patients often recover, especially if diagnosed before 50 with early treatment. Steroid monotherapy may be less effective than combination therapies for improving outcomes in these myopathy cases.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Idiopathic inflammatory myopathies (IIMs) are rare autoimmune diseases affecting muscles.
- Identifying reliable prognostic factors in IIMs is crucial for patient management.
- Previous studies have yielded inconsistent results regarding prognostic indicators.
Purpose of the Study:
- To analyze prognostic factors in a cohort of patients with idiopathic inflammatory myopathy.
- To evaluate the utility of a devised polymyositis disability score for predicting outcomes.
- To identify clinical and demographic features associated with disease prognosis.
Main Methods:
- Retrospective analysis of 77 patients diagnosed with idiopathic inflammatory myopathy over five years.
- Statistical analysis to identify significant prognostic indicators.
- Development and assessment of a polymyositis disability score.
Main Results:
- Most patients experienced partial (47%) or full (31%) recovery; mortality was 11%.
- Favorable prognostic features included onset before age 50 and symptom duration < 12 months.
- Treatment with non-steroid monotherapy regimens appeared to be a favorable indicator.
- Creatine kinase levels and histopathological classification did not significantly impact prognosis.
- Deaths primarily occurred within six months of treatment initiation.
Conclusions:
- Early symptom onset and shorter duration before presentation are favorable prognostic indicators in IIMs.
- Steroid monotherapy may be associated with poorer outcomes compared to other treatment regimens.
- Further large-scale, multi-center studies are needed to definitively establish prognostic factors and optimize treatment strategies for IIMs.